Skip to content

An Ayurvedic treatment protocol for the management of female infertility (Vandhytava) due to low anti-mullerian harmone

Efficacy of Virechana,Shatpushpa Yapana Basti,Phalkalyan Ghrita Uttara Basti,Shatpuspa Taila Nasya along with Lakshmana Churna orally in the management of female infertility (Vandhytava) w.s.r. to low AMH - An open labelled single arm clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066883
Enrollment
15
Registered
2024-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N978- Female infertility of other origin

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda, Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Married female patients of reproductive age 20- 40 years with complain of infertility. 2.Patients with AMH level less than 2.2 3.Patients with AFC less than 8 4.Patients eligible for Virechana, Yapan Basti, Uttar Basti and Nasya Karma. Patients willing to participate in trial.

Exclusion criteria

Exclusion criteria: 1.Unmarried female patients of reproductive age below 20 and above 40. 2.Patients with AMH more than or equal to 2.2 3.Patient with AFC more than or equal to 8 4.Patients are not eligible and willing for procedure Patients willing to participate in trial. Suffering from malignancies and chronic systemic diseases like, uncontrolled hypertension (Systolic blood pressure above 160 & Diastolic blood pressure above 100mmhg), uncontrolled diabetes (above the range of 160-200 mg/dl (RBS), Hepatitis C, Hepatitis B etc.. Patient with infectious diseases of the reproductive tract like tuberculosis and sexually transmitted diseases. Patient with polycystic ovarian syndrome (PCOS).

Design outcomes

Primary

MeasureTime frame
Improvement in the level of AMH. Improvement in the AFC. Timepoint: 5 months

Secondary

MeasureTime frame
Correct menstrual abnormality. induce ovulation Achieve conception Timepoint: 5 months

Countries

India

Contacts

Public Contactvd Grishma Solanki

Institute of Teaching and Research in Ayurveda, Jamnagar

grishmabams@gmail.com9427753900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026